C. Light Technologies is developing a high-resolution retinal imaging and eye tracking technology that can detect and analyze micron-scale movements in the back of the eye as a noninvasive means of assessing disease severity and progression in patients with multiple sclerosis and other neurological disorders.
Welcome to MyStrategist, an online experience like no other in the medical device industry.
MedTech Strategist, the industry's most trusted resource, will help you stay ahead of the opportunities and obstacles that are impacting your corporate strategy. We invite you to explore our coverage. Think Strategically. Subscribe Today .Browse Latest Issue
Trial MyStrategist.com and unlock 7-days of exclusive subscriber-only access to MedTech Strategist & Market PathwaysStart Trial
IDbyDNA is "democratizing" the emerging field of metagenomics by marrying genomic sequencing with state-of-the-art computational sciences to bring rapid, cost-effective precision medicine to infectious disease testing. An example of its potential: rapid characterization of the SARS-CoV-2 virus.
Virtual Investment & Partnering Summit 2020 registration is now open. On-Demand October 15th – November 20th this year's most anticipated global event will sell out. Register Today!Register Learn More
New data presented at this year’s virtual TCT conference could help put to rest safety fears around the use of paclitaxel coated devices in the peripheral vasculature. That’s good news for medtech companies eager for a market recovery.